Texas pioneered access to investigational stem cell therapy under 'Charlie's Law.'
Statute
TX HB 810 (2017), HB 3148 (2019), 22 TAC §198.6
Effective
Effective 2017, expanded 2019
Texas was the first state to formally authorize investigational adult stem cell therapies for patients with severe chronic diseases or terminal illness who have exhausted conventional treatment options. The Texas Medical Board adopted implementing rules and the Department of State Health Services maintains a registry of providers.
The requirements below are set by TX HB 810 (2017), HB 3148 (2019), 22 TAC §198.6. Compliance is the responsibility of each individual treating physician under their state license.
Statutory compliance does not equal FDA approval. The procedures discussed are investigational and have not been approved by the US Food and Drug Administration.
All procedures discussed are investigational and are not approved by the US Food and Drug Administration. Outcomes vary by patient and are not predictable in advance. Whether a procedure is appropriate is a decision made by the treating physician.
An investigational cellular procedure being explored for adults with knee osteoarthritis. Outcomes vary by patient and are not guaranteed.
Learn more OrthopedicAn investigational cellular procedure being explored for adults with partial-thickness rotator cuff tendon conditions. Outcomes vary and are not guaranteed.
Learn more PainAn investigational cellular procedure being explored for adults with chronic, imaging-documented low back pain. Outcomes vary and are not guaranteed.
Learn more OrthopedicAn investigational cellular procedure being explored for adults with chronic lateral or medial epicondylitis. Outcomes vary by patient.
Learn more OrthopedicAn investigational cellular procedure being explored for adults with hip osteoarthritis. Outcomes vary and are not guaranteed.
Learn moreTexas has enacted TX HB 810 (2017), HB 3148 (2019), 22 TAC §198.6, which sets out specific conditions under which a state-licensed physician may practice in this area. The procedures discussed here are investigational and have not been approved by the US Food and Drug Administration.
No. Adults may travel to Texas from any US state for an in-person consultation with a network physician. Whether any procedure is appropriate is a clinical decision determined by the treating physician.
Cost depends on the indication, the cell product, and the treating physician. Each physician sets their own pricing and provides a written estimate. Select Stem Cell does not collect medical fees on behalf of physicians.
Yes. Texas law requires the treating physician to provide written disclosure of investigational status and obtain informed consent prior to any procedure.
Continue Reading
We use cookies
We use strictly necessary cookies to make this site work, and (with your permission) functional and analytics cookies to improve your experience. We do not use marketing or behavioral-advertising cookies. Read our Cookie Policy.